These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1393339

  • 1. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 2. Fenfluramine stimulation of prolactin in obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Martin K, Berman S, Csernansky JG.
    Psychiatry Res; 1992 Apr; 42(1):81-92. PubMed ID: 1603884
    [Abstract] [Full Text] [Related]

  • 3. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV, Butcher G, Clare AW, Dinan TG.
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [Abstract] [Full Text] [Related]

  • 4. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers.
    Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR.
    Arch Gen Psychiatry; 1992 Jan; 49(1):21-8. PubMed ID: 1728249
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.
    Fineberg NA, Cowen PJ, Kirk JW, Montgomery SA.
    J Affect Disord; 1994 Oct; 32(2):97-104. PubMed ID: 7829769
    [Abstract] [Full Text] [Related]

  • 6. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B, Nash JF, Meltzer HY.
    Arch Gen Psychiatry; 1990 Sep; 47(9):833-9. PubMed ID: 2203327
    [Abstract] [Full Text] [Related]

  • 7. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S, John JP, Reddy LP.
    Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
    [Abstract] [Full Text] [Related]

  • 8. Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment.
    Monteleone P, Catapano F, Bortolotti F, Maj M.
    Biol Psychiatry; 1997 Aug 01; 42(3):175-80. PubMed ID: 9232209
    [Abstract] [Full Text] [Related]

  • 9. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
    Monteleone P, Catapano F, Tortorella A, Maj M.
    Neuropsychobiology; 1997 Aug 01; 36(1):8-12. PubMed ID: 9211437
    [Abstract] [Full Text] [Related]

  • 10. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Aug 01; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 11. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA, Roberts A, Montgomery SA, Cowen PJ.
    Br J Psychiatry; 1997 Sep 01; 171():280-2. PubMed ID: 9337985
    [Abstract] [Full Text] [Related]

  • 12. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May 01; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 13. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug 01; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 14. The neuroendocrine response to fenfluramine in depressives and normal controls.
    Asnis GM, Eisenberg J, van Praag HM, Lemus CZ, Friedman JM, Miller AH.
    Biol Psychiatry; 1988 May 01; 24(1):117-20. PubMed ID: 3370273
    [No Abstract] [Full Text] [Related]

  • 15. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN.
    Biol Psychiatry; 1996 Feb 15; 39(4):285-8. PubMed ID: 8645775
    [Abstract] [Full Text] [Related]

  • 16. Timing of neuroendocrine responses and effect of m-CPP and fenfluramine plasma levels in OCD.
    Hollander E, Cohen LJ, DeCaria C, Saoud JB, Stein DJ, Cooper TB, Islam NN, Liebowitz MR, Klein DF.
    Biol Psychiatry; 1993 Sep 15; 34(6):407-13. PubMed ID: 8218609
    [Abstract] [Full Text] [Related]

  • 17. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
    Park SB, Williamson DJ, Cowen PJ.
    Psychol Med; 1996 Nov 15; 26(6):1191-6. PubMed ID: 8931165
    [Abstract] [Full Text] [Related]

  • 18. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May 15; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 19. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P.
    Br J Psychiatry; 1990 Oct 15; 157():551-7. PubMed ID: 2131137
    [Abstract] [Full Text] [Related]

  • 20. Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment.
    Monteleone P, Catapano F, Di Martino S, Ferraro C, Maj M.
    Br J Psychiatry; 1997 Jun 15; 170():554-7. PubMed ID: 9330023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.